Jefferies Group’s GSK GSK Stock Holding History

Jefferies Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$8.79M	Buy	+298,662	New	+$11.3M	0.07%	215
2020 Q1	–	Sell	-33,901	Closed	-$1.99M	–	2276
2019 Q4	$1.99M	Sell	33,901 -16,030	-32%	-$892K	0.02%	1057
2019 Q3	$2.66M	Sell	49,931 -12,034	-19%	-$619K	0.02%	900
2019 Q2	$3.1M	Buy	+61,965	New	+$3.11M	0.02%	706
2018 Q3	–	Sell	-1,672	Closed	-$84K	–	2522
2018 Q2	$84K	Buy	+1,672	New	+$84.2K	﹤0.01%	2161
2018 Q1	–	Sell	-65,730	Closed	-$2.91M	–	2426
2017 Q4	$2.91M	Buy	+65,730	New	+$3.04M	0.01%	800
2017 Q2	–	Sell	-9,282	Closed	-$489K	–	2329
2017 Q1	$489K	Buy	+9,282	New	+$471K	﹤0.01%	1600
2016 Q3	–	Sell	-7,854	Closed	-$425K	–	2315
2016 Q2	$425K	Buy	+7,854	New	+$414K	﹤0.01%	1514
2016 Q1	–	Sell	-17,940	Closed	-$905K	–	2361
2015 Q4	$905K	Buy	17,940 +17,775	+10,773%	+$906K	0.01%	1216
2015 Q3	$8K	Sell	165 -41,938	-100%	-$2.18M	﹤0.01%	2180
2015 Q2	$2.19M	Buy	42,103 +31,687	+304%	+$1.78M	0.01%	869
2015 Q1	$601K	Buy	+10,416	New	+$597K	﹤0.01%	1298
2014 Q2	–	Sell	-9,889	Closed	-$661K	–	2188
2014 Q1	$661K	Sell	9,889 -98,481	-91%	-$6.66M	0.01%	1116
2013 Q4	$7.23M	Buy	108,370 +36,138	+50%	+$2.34M	0.05%	230
2013 Q3	$4.53M	Buy	72,232 +65,318	+945%	+$4.2M	0.04%	351
2013 Q2	$431K	Buy	+6,914	New	+$439K	﹤0.01%	1130

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jefferies Group's GSK Position: Q3 2022 in Review

Jefferies Group opened a new position in GSK (GSK) in Q3 2022: 298,662 shares worth $8.79M. The stake represents 0.07% of the portfolio and ranks #215 among its holdings. This is a return to the name: Jefferies Group previously reported a position in GSK as recently as Q4 2019.

Jefferies Group first reported a position in GSK in Q2 2013 and has held it in 16 quarters since. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Jefferies Group held 298,662 shares of GSK worth $8.79M as of Q3 2022.
GSK was a new Jefferies Group position in Q3 2022.
GSK made up 0.07% of Jefferies Group's portfolio in Q3 2022, its #215 holding.
Jefferies Group first reported a position in GSK in Q2 2013 and has held it in 16 quarters since.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.